Tanvirul Hye
Overview
Explore the profile of Tanvirul Hye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hye T, Hossain M, Saha D, Foyez T, Ahsan F
J Drug Target
. 2023 Apr;
31(5):1-15.
PMID: 37026714
Pulmonary arterial hypertension (PAH) is a rare pulmonary vascular disorder, wherein mean systemic arterial pressure (mPAP) becomes abnormally high because of aberrant changes in various proliferative and inflammatory signalling pathways...
2.
Hye T, Moinuddin S, Sarkar T, Nguyen T, Saha D, Ahsan F
Expert Opin Drug Deliv
. 2023 Jan;
20(3):335-348.
PMID: 36720629
Introduction: Drugs delivered via the lungs are predominantly used to treat various respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory tract infections and lung cancers, and pulmonary vascular diseases...
3.
Hye T, Dwivedi P, Li W, Lahm T, Nozik-Grayck E, Stenmark K, et al.
Am J Physiol Lung Cell Mol Physiol
. 2021 Mar;
320(6):L1025-L1037.
PMID: 33719549
Pulmonary arterial hypertension (PAH) affects more women than men, although affected females tend to survive longer than affected males. This sex disparity in PAH is postulated to stem from the...
4.
Adkins C, Nounou M, Hye T, Mohammad A, Terrell-Hall T, Mohan N, et al.
BMC Cancer
. 2015 Oct;
15:685.
PMID: 26463521
Background: Brain metastases are an increasing problem in women with invasive breast cancer. Strategies designed to treat brain metastases of breast cancer, particularly chemotherapeutics such as irinotecan, demonstrate limited efficacy....
5.
Qhattal H, Hye T, Alali A, Liu X
ACS Nano
. 2014 May;
8(6):5423-40.
PMID: 24806526
Hyaluronan-grafted liposomes (HA-liposomes) preferentially target CD44-overexpressing tumor cells in vitro via receptor-mediated endocytosis. We investigated the pharmacokinetics and biodistribution of HA-liposomes with various sizes of HA (MW 5-8, 50-60, and...